Johnson & Johnson (JNJ) EPS (Basic) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -0.10% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 284.05% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -130.68% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -15.94% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 39.99% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 13.91% |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 126.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -0.10% |
| Mar 29, 2026 | -52.43% |
| Dec 28, 2025 | 49.10% |
| Sep 28, 2025 | 91.15% |
| Jun 29, 2025 | 18.19% |
| Mar 30, 2025 | 238.05% |
| Dec 29, 2024 | -10.82% |
| Sep 29, 2024 | -89.15% |
| Jun 30, 2024 | -1.65% |
| Mar 31, 2024 | 5,278.94% |
| Dec 31, 2023 | 42.61% |
| Oct 1, 2023 | 508.15% |
| Jul 2, 2023 | 11.47% |
| Apr 2, 2023 | -101.35% |
| Oct 2, 2022 | 21.79% |
| Jul 3, 2022 | -25.53% |
| Apr 3, 2022 | -18.14% |
| Oct 3, 2021 | 3.18% |
| Jul 4, 2021 | 73.16% |
| Apr 4, 2021 | 7.00% |